Type 2 & other diabetes

The fibrosis investigating navigator in diabetes ( fibrosis investigating navigator in diabetes (FIND) ): A tool to predict liver fibrosis risk in subjects with diabetes

Diabetes Obes MetabPublished Diagnostic accuracy study

Authors' conclusion

In diabetes patients, the novel FIND score performs well in identifying subjects at risk of liver fibrosis and predicting all-cause and liver-related mortality.

Study context

Population
Subjects with diabetes, NHANES dataset (2017–2020); external biopsy validation in an Asian centre (2016–2020); prognosis in UK Biobank cohort (2006–2010)
Comparison
FIND score vs FIB-4, NFS, LiverRisk, steatosis-associated fibrosis estimator (SAFE) and MAF-5
Outcome
Prediction of fibrosis defined as LSM ≥8.0 kPa (AUROC)
Methodological detailsscore development and validation, external validation with biopsy reference, prognostic cohort analysis
  • Score development and validation
  • External validation with biopsy reference
  • Prognostic cohort analysis

Performance

As reported in the abstract

Prediction of LSM ≥8 kPa (validation set)
Test or modelAUROC
FIND0.781

FIND

AUROC0.781
  • FIND vs other available models: all p < 0.05 — AUROC consistently greater with FIND

Further findings

All-cause mortality, UK Biobank diabetic population, FIND >0.31

HR (95% CI)
FIND >0.31Adjusted models1.75 (1.62–1.89)

Liver-related mortality, UK Biobank diabetic population, FIND >0.31

HR (95% CI)
FIND >0.31Adjusted models23.59 (13.67–40.69)

FIND score cut-offs in the whole NHANES dataset (liver stiffness measurement (LSM) ≥8 kPa)

85% sensitivity cut-off of 0.16: NPV
91.9%
85% specificity cut-off of 0.31: PPV
50.6%

Staging fibrosis stages vs biopsy (external validation, Asian centre)

FIND displayed overall accuracies similar to those of the other models

Original publication

The fibrosis investigating navigator in diabetes ( FIND ): A tool to predict liver fibrosis risk in subjects with diabetes. Diabetes Obes Metab. Published 5 December 2024. doi:10.1111/dom.16109

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.